Not just PrEP: other reasons for London's HIV decline

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Open forum infectious diseases·2026

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

HIV medicine·2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

Evaluation of the psychometric properties of the Episodic Disability Questionnaire (EDQ) among women living with HIV in the United Kingdom: A self-reported repeated measure study.

PloS one·2026

Efficacy of pristinamycin in the treatment of people with Mycoplasma genitalium infection experiencing resistance-guided treatment failure: an observational study.

Sexually transmitted infections·2026

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

medRxiv : the preprint server for health sciences·2026

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

The lancet. HIV·2026

Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis.

The lancet. HIV·2026

Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

The lancet. HIV·2026

Evolving understanding of Kaposi sarcoma and associated diseases in the ART era.

The lancet. HIV·2026

Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis.

The lancet. HIV·2026

Does U=U apply during breastfeeding? An urgent research priority.

The lancet. HIV·2026

A Levinasian analysis of disability service providers' work witnessing documented institutional abuse.

Journal of intellectual & developmental disability·2026

The perception of judges regarding compulsory admission of people with severe mental illness in Portugal: a qualitative study.

Psychiatry, psychology, and law : an interdisciplinary journal of the Australian and New Zealand Association of Psychiatry, Psychology and Law·2026

[From text to scene: legal devices and care trajectories in the adoption of children with disabilities].

Cadernos de saude publica·2026

Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Expansion of Opt-Out Testing for Gonorrhea and Chlamydia to Male Detainees in the Cook County Jail - Chicago, Illinois.

Sexually transmitted diseases·2026

[Analysis of fall reports from 20 university hospitals in Germany and Austria - Findings and recommendations].

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen·2026

Related Experiment Videos

Not just PrEP: other reasons for London's HIV decline

Related Concept Videos

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment.

Prior PrEP use and discontinuation in individuals newly diagnosed with HIV.

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Evaluation of the psychometric properties of the Episodic Disability Questionnaire (EDQ) among women living with HIV in the United Kingdom: A self-reported repeated measure study.

Efficacy of pristinamycin in the treatment of people with Mycoplasma genitalium infection experiencing resistance-guided treatment failure: an observational study.

T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.

Global, regional, and national burden of HIV/AIDS, 1990-2023, with the estimated burden attributable to intimate partner violence and forecasted impacts of funding cuts through 2030: results from the Global Burden of Disease Study 2023.

Programmatic effectiveness of tuberculosis preventive treatment for people with HIV in six high-tuberculosis-burden countries (PROTECT): a prospective cohort study and meta-analysis.

Safety and immunogenicity of one or two doses of the rVSVΔG-ZEBOV-GP Ebola virus vaccine in adults and adolescents living with HIV: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.

Evolving understanding of Kaposi sarcoma and associated diseases in the ART era.

Interventions to improve viral suppression and adherence to antiretroviral therapy among people living with HIV: a systematic review and network meta-analysis.

Does U=U apply during breastfeeding? An urgent research priority.

A Levinasian analysis of disability service providers' work witnessing documented institutional abuse.

The perception of judges regarding compulsory admission of people with severe mental illness in Portugal: a qualitative study.

[From text to scene: legal devices and care trajectories in the adoption of children with disabilities].

Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation.

Expansion of Opt-Out Testing for Gonorrhea and Chlamydia to Male Detainees in the Cook County Jail - Chicago, Illinois.

[Analysis of fall reports from 20 university hospitals in Germany and Austria - Findings and recommendations].

Related Experiment Videos

Not just PrEP: other reasons for London's HIV decline

Related Concept Videos

Related Articles